Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigens

We have developed a single process for producing two key COVID-19 vaccine antigens: SARS-CoV-2 receptor binding domain (RBD) monomer and dimer. These antigens are featured in various COVID-19 vaccine formats, including SOBERANA 01 and the licensed SOBERANA 02, and SOBERANA Plus. Our approach involve...

Descripción completa

Detalles Bibliográficos
Autores principales: Boggiano-Ayo, Tammy, Palacios-Oliva, Julio, Lozada-Chang, Sumlai, Relova-Hernandez, Ernesto, Gomez-Perez, Jose, Oliva, Gonzalo, Hernandez, Lourdes, Bueno-Soler, Alexi, Montes de Oca, Daidee, Mora, Osvaldo, Machado-Santisteban, Roberto, Perez-Martinez, Dayana, Perez-Masson, Beatriz, Cabrera Infante, Yanelys, Calzadilla-Rosado, Lisandra, Ramirez, Yaima, Aymed-Garcia, Judey, Ruiz-Ramirez, Ingrid, Romero, Yamile, Gomez, Tania, Espinosa, Luis A., Gonzalez, Luis Javier, Cabrales, Annia, Guirola, Osmany, de la Luz, Kathya Rashida, Pi-Estopiñan, Franciscary, Sanchez-Ramirez, Belinda, Garcia-Rivera, Dagmar, Valdes-Balbin, Yuri, Rojas, Gertrudis, Leon-Monzon, Kalet, Ojito-Magaz, Eduardo, Hardy, Eugenio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693982/
https://www.ncbi.nlm.nih.gov/pubmed/38050488
http://dx.doi.org/10.3389/fbioe.2023.1287551

Ejemplares similares

Ejemplares similares